| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/08/2007 | WO2007025332A1 A peptide and zinc ion composition for treating diabetes and enhancing immune function |
| 03/08/2007 | WO2006122188A3 Tripeptides as hepatitis c virus inhibitors |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | WO2006090289A8 Compounds for reducing aggregation of amyloid beta-peptide |
| 03/08/2007 | US20070054865 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions associated with asthma, rhinitis, conjunctivitis, atopic dermatitis and intestinal anaphylaxis; cyclohexylalanine-L-glutamic acid-glycine |
| 03/08/2007 | US20070054864 1-[2S-(3-Tert-butylureido)-3,3-dimethylbutyryl]-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid (1S-cyclopropylaminooxalylbutyl)amide, for example; useful in treating hepatitis C infections |
| 03/08/2007 | US20070054352 Hydrolysed casein product comprising tripeptides ipp and/or vpp |
| 03/08/2007 | DE102006041064A1 New phosphorous compound useful as ligand in catalyst for e.g. hydroformylation-, hydrocyanation-, carbonylation-, hydroacylation-, hydroamination- and hydro esterification reactions |
| 03/08/2007 | CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/07/2007 | EP1760152A1 Process for producing dipeptide |
| 03/07/2007 | EP1759212A1 Identification of compounds modifying a cellular response |
| 03/07/2007 | EP1759207A1 P4has as modifiers of the igfr pathway and methods of use |
| 03/07/2007 | EP1758923A1 Peptide substance restoring myocardium function |
| 03/07/2007 | EP1758922A1 Peptide substance restoring function of respiratory organs |
| 03/07/2007 | EP1758921A2 Compounds for proteasome enzyme inhibition |
| 03/07/2007 | EP1758920A1 Bacterial efflux pump inhibitors and methods of treating bacterial infections |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926147A Nogo受体拮抗剂 Nogo receptor antagonist |
| 03/07/2007 | CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/06/2007 | US7186859 Uses for amino acid anticonvulsants |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186801 Polypeptide encoded by a nucleic acid underexpressed in stomach tumor and lung tumor |
| 03/06/2007 | US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases |
| 03/06/2007 | US7186695 Administering organic arsenic compounds such as 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide for prophylaxis of degenarative joint disease; antiarthritic agents |
| 03/01/2007 | WO2007025307A2 Inhibitors of serine proteases |
| 03/01/2007 | WO2006128082A3 Biomarkers for breast cancer |
| 03/01/2007 | WO2006072048B1 Compositions and methods for identifying modulators of hausp |
| 03/01/2007 | WO2005124341A3 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/01/2007 | US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 03/01/2007 | US20070049535 Preventive/remedy for diabetic complications using oligopeptide |
| 03/01/2007 | US20070049534 Urinary track diseases; analgesics; antiinflammatory agents; gastrointestinal disorders; premenstrual tension; respiratory system disorders; incotinence |
| 03/01/2007 | US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 03/01/2007 | US20070048794 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | CA2620621A1 Inhibitors of serine proteases |
| 03/01/2007 | CA2619406A1 Nogo receptor polypeptides and polypeptide fragments and uses thereof |
| 02/28/2007 | EP1757568A1 Method of labeling with isotope of oxygen |
| 02/28/2007 | EP1756579A2 Collections of traceable compounds and uses thereof |
| 02/28/2007 | EP1756152A2 Biologically active peptide vapeehptllteaplnpk derivatives |
| 02/28/2007 | EP1756142A1 Pseudopeptides growth hormone secretagogues |
| 02/28/2007 | EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 02/28/2007 | EP1375639B1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | CN1919865A Bioactivity peptide, preparing process and application thereof |
| 02/28/2007 | CN1302008C Synthetic method for N(2)-L-alanyl-L-glutamine dipeptide |
| 02/28/2007 | CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 02/27/2007 | US7183430 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same |
| 02/27/2007 | US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution |
| 02/27/2007 | US7183308 Multistage process for forming perindopril from acid compound |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183259 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 02/27/2007 | US7183252 Treatment of restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis related disorders, cancer, and neurodegenerative disorders. |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007020386A2 Apoe mimetic agents |
| 02/22/2007 | WO2007020012A1 A process for the preparation of perindopril erbumine |
| 02/22/2007 | WO2006066065A3 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 02/22/2007 | WO2004090103A8 Identification of novel nogo-receptors and methods related thereto |
| 02/22/2007 | US20070043103 Novel metod for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 02/22/2007 | US20070042968 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042962 Peptide dependent upregulation of telomerase expression |
| 02/22/2007 | US20070042459 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis |
| 02/22/2007 | US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 02/22/2007 | US20070041968 Methods of inducing an immune response |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2618561A1 A process for the preparation of perindopril erbumine |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1753782A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 02/21/2007 | EP1753781A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/21/2007 | EP1753775A1 Process for preparing acyclic hcv protease inhibitors |
| 02/21/2007 | EP1575900A4 N-methyl amino acids |
| 02/21/2007 | EP1515983B1 Antibacterial amide macrocycles |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179833 Hydrogenation catalysts |
| 02/20/2007 | US7179793 Fish protein hydrolysates (Salmo or Oncorhynchus); for inhibiting angiotensin converting enzyme |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179635 Peptides for use in culture media |
| 02/15/2007 | WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | WO2007017284A2 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 02/15/2007 | WO2003099854A3 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037863 Dipeptide phenyl ethers |
| 02/15/2007 | US20070037845 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof |
| 02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
| 02/15/2007 | US20070037754 Inhibitors of HIV protease; 2S-[[(N-methylamino)acetyl]amino]-N-[2R-hydroxy-3-[[(1,3-benzodioxol-5-yl)sulfonyl](2-methylpropyl)amino)-1S-(phenylmethyl)propyl]-3,3-dimethyl-butanamide |
| 02/15/2007 | US20070037753 Dipeptide containing an imidazolidinedione or a pyrimidinedione group; inhibitors of the proteasome of cathepsins, especially cathepsin S, or of other proteases |
| 02/15/2007 | US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis |